X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs TORRENT PHARMA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS TORRENT PHARMA J.B.CHEMICALS/
TORRENT PHARMA
 
P/E (TTM) x 17.7 44.4 39.9% View Chart
P/BV x 2.4 6.3 38.3% View Chart
Dividend Yield % 0.2 0.8 19.8%  

Financials

 J.B.CHEMICALS   TORRENT PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
TORRENT PHARMA
Mar-18
J.B.CHEMICALS/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs3181,550 20.5%   
Low Rs2001,144 17.4%   
Sales per share (Unadj.) Rs148.0354.7 41.7%  
Earnings per share (Unadj.) Rs19.140.1 47.6%  
Cash flow per share (Unadj.) Rs23.964.2 37.3%  
Dividends per share (Unadj.) Rs0.5014.00 3.6%  
Dividend yield (eoy) %0.21.0 18.6%  
Book value per share (Unadj.) Rs128.9273.1 47.2%  
Shares outstanding (eoy) m84.82169.22 50.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.73.8 46.1%   
Avg P/E ratio x13.633.6 40.4%  
P/CF ratio (eoy) x10.821.0 51.5%  
Price / Book Value ratio x2.04.9 40.7%  
Dividend payout %2.634.9 7.5%   
Avg Mkt Cap Rs m21,951227,897 9.6%   
No. of employees `0002.714.7 18.6%   
Total wages/salary Rs m1,84111,353 16.2%   
Avg. sales/employee Rs Th4,590.94,083.0 112.4%   
Avg. wages/employee Rs Th673.4772.3 87.2%   
Avg. net profit/employee Rs Th592.1461.3 128.3%   
INCOME DATA
Net Sales Rs m12,55160,021 20.9%  
Other income Rs m5422,988 18.1%   
Total revenues Rs m13,09363,009 20.8%   
Gross profit Rs m2,05513,493 15.2%  
Depreciation Rs m4124,086 10.1%   
Interest Rs m963,085 3.1%   
Profit before tax Rs m2,0889,310 22.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4692,529 18.6%   
Profit after tax Rs m1,6196,781 23.9%  
Gross profit margin %16.422.5 72.8%  
Effective tax rate %22.527.2 82.7%   
Net profit margin %12.911.3 114.1%  
BALANCE SHEET DATA
Current assets Rs m7,77852,623 14.8%   
Current liabilities Rs m4,35852,022 8.4%   
Net working cap to sales %27.21.0 2,718.6%  
Current ratio x1.81.0 176.4%  
Inventory Days Days55120 45.7%  
Debtors Days Days8076 105.0%  
Net fixed assets Rs m5,71385,016 6.7%   
Share capital Rs m170846 20.0%   
"Free" reserves Rs m10,54745,376 23.2%   
Net worth Rs m10,93746,222 23.7%   
Long term debt Rs m041,115 0.0%   
Total assets Rs m15,574142,432 10.9%  
Interest coverage x22.84.0 567.9%   
Debt to equity ratio x00.9 0.0%  
Sales to assets ratio x0.80.4 191.2%   
Return on assets %11.06.9 158.9%  
Return on equity %14.814.7 100.9%  
Return on capital %20.014.2 140.7%  
Exports to sales %48.70-   
Imports to sales %7.10-   
Exports (fob) Rs m6,115NA-   
Imports (cif) Rs m889NA-   
Fx inflow Rs m6,16914,580 42.3%   
Fx outflow Rs m1,2853,600 35.7%   
Net fx Rs m4,88410,980 44.5%   
CASH FLOW
From Operations Rs m1,3978,942 15.6%  
From Investments Rs m-320-47,070 0.7%  
From Financial Activity Rs m-1,19634,174 -3.5%  
Net Cashflow Rs m-102-3,655 2.8%  

Share Holding

Indian Promoters % 55.4 71.5 77.5%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 7.0 48.3%  
FIIs % 3.9 12.6 31.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 8.8 420.5%  
Shareholders   30,437 26,511 114.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   ALEMBIC PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 207 Points Higher; Healthcare Stocks Witness Buying(Closing)

Indian share markets continued to trade in the green during the closing hours of the trading session and ended the day on a positive note.

Related Views on News

TORRENT PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 13.3% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 13.3% YoY). Sales on the other hand came in at Rs 19 bn (up 36.2% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (4QFY18); Net Profit Up 10.7% (Quarterly Result Update)

Jun 1, 2018 | Updated on Jun 1, 2018

For the quarter ended March 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 10.7% YoY). Sales on the other hand came in at Rs 17 bn (up 20.1% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

The Biggest Mistake You Can Make in this Market (and 3 Stocks to Buy Now!)(Profit Hunter)

Aug 3, 2018

This price pattern can help you identify stocks on the verge of a turnaround.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

Is Franklin India Smaller Companies Fund Worth Your Money(Outside View)

Aug 2, 2018

Although positioned as a small cap fund, Franklin India Smaller Companies Fund has been investing a significant portion of its assets in mid-caps along with a nominal exposure to large caps.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Aug 14, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS